Ambrisentan Zentiva (ambrisentan)
Generic
- Region
- 🇪🇺 EU
- Active substance
- ambrisentan
- Company
- Zentiva k.s.
- Status
- Application withdrawn
- Therapeutic area
- Hypertension, Pulmonary
- Designations
- Generic
- Application
- EMEA/H/C/004955
- ATC
- C02KX02
- Official record
- www.ema.europa.eu
Indication
Treatment of pulmonary arterial hypertension.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Ambrisentan Viatris (previously Ambrisentan Mylan) Authorised · Viatris Limited
- 🇪🇺 Volibris Authorised · GlaxoSmithKline Trading Services Limited
Follow Ambrisentan Zentiva
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.